Saved in:
Bibliographic Details
Main Authors: Tadese, Dawit Adisu, Mwangi, James, Michira, Brenda B, Wang, Yi, Cao, Kaixun, Yang, Min, Khalid, Mehwish, Wang, Ziyi, Lu, Qiumin, Lai, Ren
Format: Artículo científico
Language:en
Published: International journal of molecular sciences 2025
Subjects:
Online Access:https://pubmed.ncbi.nlm.nih.gov/40806291/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266165161164801
author Tadese, Dawit Adisu
Mwangi, James
Michira, Brenda B
Wang, Yi
Cao, Kaixun
Yang, Min
Khalid, Mehwish
Wang, Ziyi
Lu, Qiumin
Lai, Ren
author_facet Tadese, Dawit Adisu
Mwangi, James
Michira, Brenda B
Wang, Yi
Cao, Kaixun
Yang, Min
Khalid, Mehwish
Wang, Ziyi
Lu, Qiumin
Lai, Ren
Tadese, Dawit Adisu
Mwangi, James
Michira, Brenda B
Wang, Yi
Cao, Kaixun
Yang, Min
Khalid, Mehwish
Wang, Ziyi
Lu, Qiumin
Lai, Ren
collection PubMed - marine biology
contents D-Tryptophan Promotes Skin Wound Healing via Extracellular Matrix Remodeling in Normal and Diabetic Models. Tadese, Dawit Adisu Mwangi, James Michira, Brenda B Wang, Yi Cao, Kaixun Yang, Min Khalid, Mehwish Wang, Ziyi Lu, Qiumin Lai, Ren Animals Wound Healing Diabetes Mellitus, Experimental Mice Extracellular Matrix Tryptophan Male Hypoxia-Inducible Factor 1, alpha Subunit Skin Mice, Inbred C57BL Disease Models, Animal Apoptosis Vascular Endothelial Growth Factor A Diabetic wounds are a devastating complication that cause chronic pain, recurrent infections, and limb amputations due to impaired healing. Despite advances in wound care, existing therapies often fail to address the underlying molecular dysregulation, highlighting the need for innovative and safe therapeutic approaches. Among these, D-amino acids such as D-tryptophan (D-Trp) have emerged as key regulators of cellular processes; however, their therapeutic potential in diabetic wounds remains largely unexplored. Here, we investigate the therapeutic potential of D-Trp in streptozotocin (STZ)-induced diabetic mice, comparing it with phosphate-buffered saline (PBS) controls and vascular endothelial growth factor (VEGF) as a positive control. Wound healing, inflammation, and histopathology were assessed. Protein and gene expression were analyzed via Western blot and RT-qPCR, respectively. Biolayer interferometry (BLI) measured the binding of D-Trp to hypoxia-inducible factor-1α (HIF-1α). D-Trp accelerated wound healing by modulating extracellular matrix (ECM) remodeling, signaling, and apoptosis. It upregulated matrix metalloproteinases (MMP1, MMP3, MMP-9), Janus kinase 2 (JAK2), and mitogen-activated protein kinase (MAPK) proteins while reducing pro-inflammatory cytokines (tumor necrosis factor-α [], interleukin-1β [], ). D-Trp also suppressed caspase-3 and enhanced angiogenesis through HIF-1α activation. These findings suggest that D-Trp promotes healing by boosting ECM turnover, reducing inflammation, and activating MAPK/JAK pathways. Thus, D-Trp is a promising therapeutic for diabetic wounds.
format Artículo científico
id pubmed_40806291
institution PubMed
language en
publishDate 2025
publisher International journal of molecular sciences
record_format pubmed
spellingShingle D-Tryptophan Promotes Skin Wound Healing via Extracellular Matrix Remodeling in Normal and Diabetic Models.
Tadese, Dawit Adisu
Mwangi, James
Michira, Brenda B
Wang, Yi
Cao, Kaixun
Yang, Min
Khalid, Mehwish
Wang, Ziyi
Lu, Qiumin
Lai, Ren
Animals
Wound Healing
Diabetes Mellitus, Experimental
Mice
Extracellular Matrix
Tryptophan
Male
Hypoxia-Inducible Factor 1, alpha Subunit
Skin
Mice, Inbred C57BL
Disease Models, Animal
Apoptosis
Vascular Endothelial Growth Factor A
D-Tryptophan Promotes Skin Wound Healing via Extracellular Matrix Remodeling in Normal and Diabetic Models. Tadese, Dawit Adisu Mwangi, James Michira, Brenda B Wang, Yi Cao, Kaixun Yang, Min Khalid, Mehwish Wang, Ziyi Lu, Qiumin Lai, Ren Animals Wound Healing Diabetes Mellitus, Experimental Mice Extracellular Matrix Tryptophan Male Hypoxia-Inducible Factor 1, alpha Subunit Skin Mice, Inbred C57BL Disease Models, Animal Apoptosis Vascular Endothelial Growth Factor A Diabetic wounds are a devastating complication that cause chronic pain, recurrent infections, and limb amputations due to impaired healing. Despite advances in wound care, existing therapies often fail to address the underlying molecular dysregulation, highlighting the need for innovative and safe therapeutic approaches. Among these, D-amino acids such as D-tryptophan (D-Trp) have emerged as key regulators of cellular processes; however, their therapeutic potential in diabetic wounds remains largely unexplored. Here, we investigate the therapeutic potential of D-Trp in streptozotocin (STZ)-induced diabetic mice, comparing it with phosphate-buffered saline (PBS) controls and vascular endothelial growth factor (VEGF) as a positive control. Wound healing, inflammation, and histopathology were assessed. Protein and gene expression were analyzed via Western blot and RT-qPCR, respectively. Biolayer interferometry (BLI) measured the binding of D-Trp to hypoxia-inducible factor-1α (HIF-1α). D-Trp accelerated wound healing by modulating extracellular matrix (ECM) remodeling, signaling, and apoptosis. It upregulated matrix metalloproteinases (MMP1, MMP3, MMP-9), Janus kinase 2 (JAK2), and mitogen-activated protein kinase (MAPK) proteins while reducing pro-inflammatory cytokines (tumor necrosis factor-α [], interleukin-1β [], ). D-Trp also suppressed caspase-3 and enhanced angiogenesis through HIF-1α activation. These findings suggest that D-Trp promotes healing by boosting ECM turnover, reducing inflammation, and activating MAPK/JAK pathways. Thus, D-Trp is a promising therapeutic for diabetic wounds.
title D-Tryptophan Promotes Skin Wound Healing via Extracellular Matrix Remodeling in Normal and Diabetic Models.
topic Animals
Wound Healing
Diabetes Mellitus, Experimental
Mice
Extracellular Matrix
Tryptophan
Male
Hypoxia-Inducible Factor 1, alpha Subunit
Skin
Mice, Inbred C57BL
Disease Models, Animal
Apoptosis
Vascular Endothelial Growth Factor A
url https://pubmed.ncbi.nlm.nih.gov/40806291/